Valuein

Overview

PROGRESSIVE CORP/OH/

PGRNYSEFinancialsFire, Marine & Casualty InsuranceCIK 0000080661Large-cap benchmark

Latest 10-K: FY2025, filed Mar 2, 2026 · Open the 10-K (Inline XBRL) ↗

Revenue
$87.67B
16.3%YoYup from FY2024
TotalRevenue
Gross profit
Not reported
Net income
$11.31B
33.3%YoYup from FY2024
NetIncome
Diluted EPS
$19.23
33.5%YoYup from FY2024
EPSDiluted
Diluted shares
588.1M
0.1%YoYup from FY2024
WeightedAvgSharesDiluted

At a glance

Growth

  • PROGRESSIVE CORP/OH/ reported revenue of $87.67B for fiscal 2025, up 16.3% from fiscal 2024.
  • Revenue grew faster than the median S&P 500 member in 3 of the last 5 fiscal years.

Profitability

  • Net margin was 12.9%, against a median of 12.8% across S&P 500 members for the same fiscal year.

Per share

  • Diluted EPS was $19.23, up 33.5% from the prior year.
Loading insider and institutional summary

Written from the filed figures on this page by fixed rules — no AI.

Data as of Oct 31, 2026 · Sources: SEC EDGAR 10-K

Financial statements

Annual figures from the 10-K, most recent fiscal year first.

Income Statement

5 annual periods

Chip: YoY change.

Income Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Revenue
$87.67B16.3%up
Benchmark median 6.4%
$75.37B21.4%up
Benchmark median 4.5%
$62.11B25.2%up
Benchmark median 4.8%
$49.61B4.0%up
Benchmark median 10.3%
$47.70B11.8%up
Benchmark median 13.8%
16.4%
Benchmark median 6.6%
Gross Profit
Median of 315 / 498
—
—
—
—
—
—
Benchmark median 6.2%
Operating Income
Median of 373 / 498
—
—
—
—
—
—
Benchmark median 7.2%
Net Income
$11.31B33.3%up
Benchmark median 4.8%
$8.48B117.3%up
Benchmark median 5.7%
$3.90B440.6%up
Benchmark median 1.9%
$0.72B78.5%down
Benchmark median 1.3%
$3.35B41.3%down
Benchmark median 33.9%
35.5%
Benchmark median 4.1%
EPS (Diluted)
$19.2333.5%up
Benchmark median 6.2%
$14.40118.8%up
Benchmark median 7.9%
$6.58457.6%up
Benchmark median 1.9%
$1.1879.2%down
Benchmark median 1.5%
$5.6641.4%down
Benchmark median 34.8%
35.8%
Benchmark median 5.6%

Balance Sheet

5 annual periods

Chip: YoY change.

Balance Sheet, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Total Assets
$123.04B16.4%up
Benchmark median 5.6%
$105.75B19.2%up
Benchmark median 3.4%
$88.69B17.5%up
Benchmark median 4.1%
$75.47B6.1%up
Benchmark median 2.2%
$71.13B11.0%up
Benchmark median 6.7%
14.7%
Benchmark median 4.7%
Total Liabilities
Median of 357 / 498
$92.72B15.7%up
Benchmark median 6.4%
$80.15B17.2%up
Benchmark median 1.9%
$68.41B14.8%up
Benchmark median 2.9%
$59.57B12.6%up
Benchmark median 2.0%
$52.90B12.4%up
Benchmark median 5.2%
15.1%
Benchmark median 4.4%
Stockholders' Equity
$30.32B18.5%up
Benchmark median 6.8%
$25.59B26.2%up
Benchmark median 5.4%
$20.28B27.6%up
Benchmark median 7.3%
$15.89B12.8%down
Benchmark median 2.5%
$18.23B7.0%up
Benchmark median 9.0%
13.6%
Benchmark median 6.1%
Cash & Equivalents
—
—
—
—
—
—
Benchmark median 2.0%
Total Debt
$6.90B0.1%up
Benchmark median 2.1%
$6.89B0.1%up
Benchmark median 0.2%
$6.89B7.8%up
Benchmark median 0.3%
$6.39B30.4%up
Benchmark median 0.1%
$4.90B9.2%down
Benchmark median -0.1%
8.9%
Benchmark median 4.3%

Cash Flow Statement

5 annual periods

Chip: YoY change.

Cash Flow Statement, annual, newest fiscal year first. 4Y CAGR: compound annual growth from the oldest to the newest year shown. Muted line: large-cap benchmark median change. Line under a label: how many large-cap benchmark companies its median rests on.
Line itemFY2025FY2024FY2023FY2022FY20214Y CAGR
Operating Cash Flow
$17.55B16.1%up
Benchmark median 6.3%
$15.12B42.1%up
Benchmark median 4.8%
$10.64B55.4%up
Benchmark median 9.9%
$6.85B11.8%down
Benchmark median -0.7%
$7.76B12.4%up
Benchmark median 10.7%
22.6%
Benchmark median 7.0%
Capital Expenditures
$348.00M22.1%up
Benchmark median 5.4%
$285.00M13.1%up
Benchmark median 2.8%
$252.00M13.7%down
Benchmark median 11.3%
$292.00M19.9%up
Benchmark median 14.0%
$243.50M8.9%up
Benchmark median 8.1%
9.3%
Benchmark median 9.0%
Free Cash Flow
Median of 378 / 498
$17.20B15.9%up
Benchmark median 7.3%
$14.83B42.8%up
Benchmark median 6.1%
$10.39B58.5%up
Benchmark median 8.8%
$6.56B12.8%down
Benchmark median -11.3%
$7.52B12.5%up
Benchmark median 10.2%
23.0%
Benchmark median 4.9%

n/m: not meaningful — the base (the prior year, or the first year for the CAGR) was zero or negative, or a per-share figure’s share basis changed (stock split). “—” means the figure is not available.

Benchmark median = median of the companies in the benchmark universe on Dec 31 of each fiscal year, from their own 10-K filings; a change counts only companies whose prior year was positive. Each median uses every member that reports the line item; where fewer than 80% do (banks and insurers file no gross profit), the row names how many. Published where at least 250 companies report it. Updated 2026-10-27. This compares reported figures, not share-price returns. Methodology

Ratios & valuation

FY2025

Every ratio read two ways: Wall Street’s popular formula and the value investor’s stricter one. Same question, same unit. Pick a ratio.

Valuation · Earnings yield

What a dollar of market value earned

8.4%

Wall Street

on net earnings

FY2024 6.0%

12.8%

Value investor

on free cash flow

FY2024 10.5%

Gap +4.4 pts: Value-investor figure 4.4 points higher

How it’s calculated

Wall Street · on net earnings

Diluted EPS ÷ fiscal-year-end share price (1 ÷ P/E)

pe_ratio (ratio table)

P/E 11.8×

Value investor · on free cash flow

(Operating cash flow − capital expenditures) ÷ market capitalisation (fiscal-year-end close × weighted-average diluted shares)

free cash flow ÷ market cap

Each ratio measures one thing two ways, in the same unit: the popular formula, then a stricter one, so a lower figure is the stricter reading. Gap = value-investor figure minus Wall Street figure, from the figures shown.

Price-based ratios use the fiscal-year-end closing price. Free cash flow = operating cash flow − capital expenditures (we compute it; filings rarely report it). n/m = not meaningful (denominator ≤ 0); “—” = not reported. Each ratio’s formulas are under “How it’s calculated”.

Loading capital allocation

Smart money

Loading insider and institutional activity

Showing the most recent 5 annual periods. Get longer history on the Pro plan, or the full history (1993–present) plus the smart-money dataset and webhooks on Institutional.

Peers, filings & research

Loading sector peers
Loading recent filings

Research Reports

No published research on PGR yet.

Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows on data pinned to its SEC filing. Be the first: run equity_research_brief on PGR and publish the result to your public profile.

Loading the data behind this page

Cite this page

Data as of Oct 31, 2026. Canonical address: https://valuein.biz/data/PGR

APA-style text
Valuein. (2026, October 31). PROGRESSIVE CORP/OH/ (PGR) financial statements, earnings power and smart-money summary [Data set]. Source: SEC EDGAR filings. https://valuein.biz/data/PGR
BibTeX
@misc{valuein_pgr_2026,
  author = {{Valuein}},
  title = {PROGRESSIVE CORP/OH/ (PGR) financial statements, earnings power and smart-money summary},
  year = {2026},
  howpublished = {\url{https://valuein.biz/data/PGR}},
  note = {Data as of 2026-10-31; source: SEC EDGAR filings}
}
Open 10-K in SEC Inline XBRL viewer

10-K filed Mar 2, 2026 · accession 0000080661-26-000086

Agents: every figure Valuein's tools return carries a fact_id that traces to its SEC filing.

point-in-time · survivorship-free · every number traceable to its SEC filing

Index names are trademarks of their owners; Valuein is not affiliated with or endorsed by any index provider.